3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
45
Multiple Myeloma
39
Lymphoma, Large B-Cell, Diffuse
37
Burkitt Lymphoma
32
Lymphoma
30
Lymphoma, Non-Hodgkin
28
Leukemia, Myeloid, Acute
28
Breast Neoplasms
26
Recurrence
25
Neoplasms
22
Lymphoma, B-Cell
22
Leukemia, Lymphocytic, Chronic, B-Cell
22
Myelodysplastic Syndromes
19
Lymphoma, Follicular
18
Triple Negative Breast Neoplasms
17
Melanoma
16
Hodgkin Disease
16
Leukemia
15
Hematologic Neoplasms
15
Neuroblastoma
14
Ovarian Neoplasms
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma, Mantle-Cell
11
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10
Osteosarcoma
9
Neoplasm Metastasis
9
Leukemia, Biphenotypic, Acute
9
Sarcoma
8
Rhabdomyosarcoma
8
Pancreatic Neoplasms
8
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
amino-acid, glucose, and electrolyte solution
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Cyclophosphamide
×
90 days
×
Clear all
No trials found.